The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus (HPV) Assay in comparison to the DNA-based Hybrid Capture 2 HPV Test in 2 consecutive screening rounds with a 6-year interval in Germany
The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus (HPV) Assay in comparison to the DNA-based Hybrid Capture 2 HPV Test in 2 consecutive screening rounds with a 6-year interval in Germany
description
article
@en
im Oktober 2018 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в жовтні 2018
@uk
name
The longitudinal clinical perf ...... h a 6-year interval in Germany
@en
The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus
@nl
type
label
The longitudinal clinical perf ...... h a 6-year interval in Germany
@en
The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus
@nl
altLabel
Longitudinal Clinical Performa ...... h a 6-Year Interval in Germany
@en
prefLabel
The longitudinal clinical perf ...... h a 6-year interval in Germany
@en
The longitudinal clinical performance of the RNA-based AHPV Human Papillomavirus
@nl
P2093
P50
P356
P1476
Longitudinal Clinical Performa ...... h a 6-Year Interval in Germany
@en
P2093
Angelika Iftner
Annette Staebler
Astrid Woll-Herrmann
Barbara Holz
Claus Hann von Weyhern
Diethelm Wallwiener
Felix Neis
Juliane Haedicke-Jarboui
Klaus-Joachim Neis
Melanie Henes
P356
10.1128/JCM.01177-18
P407
P577
2019-01-02T00:00:00Z